Brian J. Caveney, EVP, President of BLS, CMO and CSO of Labcorp Holdings Inc., filed a Form 4 on November 12, 2026, disclosing a sale of common stock that occurred on November 10, 2026.

Key Highlights

  • Reporting person: Brian J. Caveney, identified as EVP, Pres of BLS, CMO and CSO of Labcorp Holdings Inc. (NYSE:LH)
  • Transaction: Disposition (transaction code S) of 2,000 shares of common stock on November 10, 2026
  • Sale price: $372.0401 per share, as reported in the filing
  • Remaining holdings: 34,562.0463 shares of common stock beneficially owned directly following the transaction
  • ESPP shares included: The post-transaction total includes 70.1229 shares acquired on June 30, 2026 under the Labcorp Holdings Inc. 2025 Employee Stock Purchase Plan
  • Filing date: November 12, 2026, signed by Kathryn W. Kyle as attorney-in-fact for Brian J. Caveney

Caveney's November 2026 Share Disposition at Labcorp Holdings

According to the Form 4 filed with the SEC on November 12, 2026, Brian J. Caveney disposed of 2,000 shares of Labcorp Holdings Inc. common stock on November 10, 2026, at a price of $372.0401 per share. The transaction is coded "S," indicating a sale. Caveney holds the titles of EVP, President of BLS, CMO and CSO at the company, which trades on the New York Stock Exchange under the symbol LH.

Following the reported transaction, the filing states that Caveney directly beneficially owns 34,562.0463 shares of common stock. The filing notes in its explanation of responses that this amount includes 70.1229 shares acquired on June 30, 2026 under the Labcorp Holdings Inc. 2025 Employee Stock Purchase Plan. All reported ownership is listed as direct. No derivative securities transactions were reported in Table II of the filing.

The Form 4 was signed by Kathryn W. Kyle as attorney-in-fact for Brian J. Caveney and filed on November 12, 2026. The filing indicates it was made by one reporting person and does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan, as that checkbox was not checked.

What Was Disclosed

Labcorp Holdings Inc. officer Brian J. Caveney reported a sale of 2,000 shares of common stock at $372.0401 on November 10, 2026, leaving him with 34,562.0463 directly owned shares, including 70.1229 shares from the company's 2025 Employee Stock Purchase Plan.